Manning & Napier Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$39.9K Buy
45
+4
+10% +$4.05K ﹤0.01% 371
2025
Q4
$44.3K Sell
41
-14
-25% -$13.4K ﹤0.01% 340
2025
Q3
$42K Buy
+55
New +$40.9K ﹤0.01% 344
2025
Q1
Sell
-657
Closed -$507K 292
2024
Q4
$507K Buy
+657
New +$544K 0.01% 263
2017
Q3
$1.97M Sell
23,077
-1,725
-7% -$141K 0.02% 277
2017
Q2
$2.04M Sell
24,802
-2,475
-9% -$202K 0.02% 275
2017
Q1
$2.29M Buy
27,277
+5,061
+23% +$405K 0.02% 275
2016
Q4
$1.63M Buy
22,216
+2,230
+11% +$166K 0.01% 283
2016
Q3
$1.6M Sell
19,986
-2,780
-12% -$223K 0.01% 273
2016
Q2
$1.79M Sell
22,766
-7,974
-26% -$600K 0.01% 269
2016
Q1
$2.21M Sell
30,740
-6,210
-17% -$470K 0.01% 258
2015
Q4
$3.11M Sell
36,950
-4,077,747
-99% -$338M 0.02% 224
2015
Q3
$344M Sell
4,114,697
-458,640
-10% -$38.7M 1.85% 17
2015
Q2
$382M Buy
4,573,337
+4,423,754
+2,957% +$337M 1.66% 21
2015
Q1
$10.9M Sell
149,583
-1,899
-1% -$135K 0.05% 157
2014
Q4
$10.4M Buy
151,482
+3,364
+2% +$227K 0.05% 160
2014
Q3
$9.61M Sell
148,118
-9,037
-6% -$572K 0.04% 171
2014
Q2
$9.77M Buy
157,155
+32,311
+26% +$1.93M 0.04% 178
2014
Q1
$7.35M Buy
124,844
+3,004
+2% +$168K 0.03% 204
2013
Q4
$6.21M Sell
121,840
-64,051
-34% -$3.21M 0.03% 188
2013
Q3
$9.36M Buy
185,891
+429
+0.2% +$22.5K 0.04% 163
2013
Q2
$9.11M Buy
+185,462
New +$10.1M 0.05% 166

Other funds holding LLY

Manning & Napier Advisors's LLY Position: Q1 2026 in Review

Manning & Napier Advisors increased its Eli Lilly (LLY) stake by 9.8% in Q1 2026, buying an estimated $4.05K and bringing the position to 45 shares worth $39.9K. The position accounts for ﹤0.01% of the portfolio, ranked #371.

Manning & Napier Advisors first reported a position in LLY in Q2 2013 and has held it in 22 quarters since. The position peaked at $382M in Q2 2015. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Manning & Napier Advisors held 45 shares of Eli Lilly worth $39.9K as of Q1 2026.
  • Manning & Napier Advisors bought 4 Eli Lilly shares in Q1 2026, an estimated $4.05K.
  • Eli Lilly made up ﹤0.01% of Manning & Napier Advisors's portfolio in Q1 2026, its #371 holding.
  • Manning & Napier Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 22 quarters since.
  • Manning & Napier Advisors's Eli Lilly position peaked at $382M in Q2 2015.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Manning & Napier Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.